FORMULARY DECISION
Semaglutide : Wegovy
SMC2497 : For the treatment of obesity prioritised for use in those with a BMI of ≥38kg/m2 (≥35kg/m2 for members of minority ethnic groups known to be at equivalent risk of the consequences of obesit...
We have found 13 results when searching "Semaglutide"
SMC2497 : For the treatment of obesity prioritised for use in those with a BMI of ≥38kg/m2 (≥35kg/m2 for members of minority ethnic groups known to be at equivalent risk of the consequences of obesit...
SMC2092 : Treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise. SMC restriction: In addition to other oral anti-diabetic medicines, or as an a...
SMC2287 : For the treatment of adults with insufficiently controlled type 2 diabetes (T2D) to improve glycaemic control as an adjunct to diet and exercise: As monotherapy when metformin is considered...